595 PROSPECTIVE, RANDOMIZED, COMPARATIVE STUDY OF HIGH DOSE INTRAVESICAL EPIRUBICIN VERSUS BCG FOR PROPHYLAXIS IN INTERMEDIATE RISK SUPERFICIAL BLADDER TUMORS

Autor:	D. Malovrouvas, I. Dimitriadis, M. Melekos, C. Tsolos, G. Moutzouris, M. Lykourinas, E. Michail, I. Gezerlis
Rok vydání:	2007
Předmět:	medicine.medical_specialty business.industry Urology medicine Intermediate risk business Surgery Epirubicin medicine.drug
Zdroj:	European Urology Supplements. 6:171
ISSN:	1569-9056
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b9def6692ee915e883676af8de9cf6bb https://doi.org/10.1016/s1569-9056(07)60593-4 Zobrazit plný text záznamu Full Text from ScienceDirect